Stereotactic Injection of Hydrogel into a Post-Stroke Mouse Model
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:59 min • August 29th, 2025
Loading...
Overview
This article details a method for delivering a microporous hydrogel to a post-stroke mouse model. The hydrogel serves as a biomaterial scaffold to promote cellular infiltration and new blood vessel formation.
Key Study Components
Area of Science
- Neuroscience
- Neurotherapeutics
- Biomaterials
Background
- Stroke leads to significant neuronal damage and impaired vasculature.
- Hydrogels can mimic the extracellular matrix.
- Effective treatment strategies are needed to enhance recovery post-stroke.
- This study explores the use of hydrogel for neuroregeneration.
Purpose of Study
- To investigate the delivery of hydrogel to a stroke site in the brain.
- To assess the hydrogel's ability to support neuronal recovery.
- To evaluate the potential of hydrogel in neurotherapeutic applications.
Methods Used
- Mouse model of stroke was used for experimentation.
- Microporous hydrogel was injected at a controlled flow rate.
- Post-injection, the hydrogel was allowed to crosslink.
- Monitoring of recovery post-surgery was conducted.
Main Results
- The hydrogel successfully formed a scaffold at the stroke site.
- Cellular infiltration and new blood vessel formation were observed.
- Hydrogel delivery did not cause additional tissue damage.
- The method demonstrates potential for future neurotherapeutic strategies.
Conclusions
- Hydrogel delivery is a promising approach for post-stroke recovery.
- The study supports further investigation into hydrogel applications in neuroscience.
- Future research may enhance the efficacy of neurotherapeutic interventions.
Frequently Asked Questions
What is the significance of using hydrogels in neurotherapeutics?
Hydrogels can mimic the extracellular matrix, supporting cellular infiltration and tissue regeneration.
How was the hydrogel delivered to the stroke site?
The hydrogel was injected using a syringe at a controlled flow rate to ensure gradual diffusion.
What were the main findings of the study?
The hydrogel facilitated cellular infiltration and new blood vessel formation without causing additional damage.
What animal model was used in this research?
An anesthetized post-stroke mouse model was utilized for the experiments.
What is the potential impact of this research?
This research may lead to improved therapeutic strategies for stroke recovery.
How does the hydrogel function at the cellular level?
The hydrogel acts as a scaffold that supports cell migration and new blood vessel formation.
Executive Industry Relevance
Stereotactic hydrogel injection into post-stroke mouse brains enables precise delivery of biomaterial scaffolds that mimic the extracellular matrix, supporting cellular infiltration and angiogenesis. This approach addresses a critical challenge in neurotherapeutic discovery by providing a reproducible platform for evaluating regenerative strategies in disease-relevant models. The method enhances predictive confidence for early-stage neuroregeneration programs and informs portfolio triage decisions in CNS therapeutic pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neuroregenerative hypotheses in a controlled, post-stroke environment.
- Supports biological de-risking by modeling scaffold-induced cellular and vascular responses.
- Facilitates functional target validation for biomaterial-based interventions.
- Provides predictive data to inform go/no-go decisions in neurotherapeutic portfolios.
Screening & Assay Development
- Establishes a validated in vivo system for testing hydrogel formulations and delivery parameters.
- Standardizes injection coordinates and flow rates for reproducible scaffold formation.
- Enables quantitative assessment of cellular infiltration and angiogenesis post-injection.
- Supports downstream screening of candidate biomaterials for CNS repair.
Translational & Preclinical Research
- Aligns with disease-relevant models for translational biomarker development in stroke recovery.
- Provides continuity from discovery through preclinical validation of neuroregenerative strategies.
- De-risks advancement of hydrogel-based therapies by demonstrating scaffold retention and tissue compatibility.
- Supports risk-adjusted progression of CNS biomaterial candidates.
Pipeline & Workflow Integration
This stereotactic hydrogel injection protocol integrates into the early discovery-to-preclinical continuum for neuroregenerative therapeutics.
- Discovery Biology: Enables hypothesis testing on scaffold-induced repair mechanisms in vivo.
- Screening: Provides a reproducible assay for evaluating hydrogel performance and biological outcomes.
- Analytics: Delivers quantitative readouts of cellular infiltration and angiogenesis for comparative analysis.
- Translational Research: Bridges discovery findings to preclinical validation in disease-relevant models.
- Enterprise Reuse: Offers a standardized platform adaptable to diverse biomaterial and CNS repair studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in neuroregeneration research.
- Operational Value: Promotes standardization, reproducibility, and scalability of in vivo scaffold delivery.
- Strategic Value: Informs go/no-go decisions and enhances capital efficiency in CNS therapeutic development.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neurotherapeutic candidates.
Implementation Considerations
- Requires expertise in stereotactic surgery and post-stroke animal model handling.
- Needs precise instrumentation for controlled hydrogel injection and scaffold formation.
- Demands cross-team standardization of injection parameters and post-operative monitoring.
- Adaptable to various hydrogel formulations and CNS injury models with protocol optimization.
- Potential limitations include model-specific variability and technical skill requirements.
Biopharma FAQs
Why does null hypothesis testing matter for hydrogel scaffold validation?
Null hypothesis testing ensures that observed cellular infiltration and angiogenesis following hydrogel injection are statistically significant and not due to random variation. This rigor is essential for target validation and for advancing biomaterial candidates in neuroregeneration pipelines.
How does independent variable isolation fit the stereotactic injection workflow?
By controlling injection coordinates, flow rate, and hydrogel volume, the protocol isolates the effects of the hydrogel scaffold on tissue response. This isolation enables clear attribution of biological outcomes to the intervention, supporting mechanistic de-risking in discovery research.
What do quantitative dependent variable measurements enable in this model?
Quantitative assessment of cellular infiltration and new blood vessel formation provides objective metrics for comparing hydrogel formulations and delivery strategies. These measurements support data-driven decisions in candidate selection and optimization.
Why are replication requirements critical for cross-functional collaboration?
Standardized replication of the injection and scaffold formation process ensures reproducibility across teams, facilitating reliable data sharing and collaborative evaluation of biomaterial performance in multi-site R&D environments.
What statistical analysis capabilities are required before hydrogel implementation?
Robust statistical analysis is needed to compare biological outcomes across experimental groups, validate scaffold efficacy, and establish confidence in translational potential. This includes appropriate controls, sample size calculations, and significance testing aligned with enterprise R&D standards.
09:42
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Related Videos
0 Views
06:07
Modeling Stroke in Mice: Focal Cortical Lesions by Photothrombosis
Related Videos
0 Views
10:17
Preparation and Characterization of Graphene-Based 3D Biohybrid Hydrogel Bioink for Peripheral Neuroengineering
Related Videos
0 Views
03:16
Intravenous Delivery of Receptor Blockers to Reduce Brain Edema in a Mouse Model
Related Videos
0 Views
03:58
Stereotaxic Injection of Viral Vectors for Glial Cell Reprogramming in a Mouse Model
Related Videos
0 Views
08:40
Photothrombotic Ischemia: A Minimally Invasive and Reproducible Photochemical Cortical Lesion Model for Mouse Stroke Studies
Related Videos
0 Views
08:36
A Versatile Murine Model of Subcortical White Matter Stroke for the Study of Axonal Degeneration and White Matter Neurobiology
Related Videos
0 Views
09:57
Intranasal Delivery of Therapeutic Stem Cells to Glioblastoma in a Mouse Model
Related Videos
0 Views
09:41
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
Related Videos
0 Views
04:46
Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations
Related Videos
0 Views
Last updated: 18 July 2026